Skip to content
PoliTrackerPrototype - alpha version 0.1
← Policies

Proposed

Bill · 119th Congress · HR 8908

STOP GAMES Act of 2026

Refreshed 6 h ago

Introduced 2026-05-19Topic: health care · governance ethics

Summary

AI-generated summary, report an error

This bill changes federal rules for citizen petitions that ask the Food and Drug Administration (FDA) to act on applications for generic drugs and biosimilars. It would require such petitions to be filed within 60 days after the petitioner first learned the information the petition is based on. It would let the FDA deny a petition at any time if it finds the main purpose is to delay approval of an application, lists factors for making that finding, and requires those cases to be referred to the Federal Trade Commission. It would require courts to dismiss certain lawsuits challenging these drug applications if a petition was not filed first or was filed late, and it adds new details to the FDA's reports to Congress on petitions.

Full text and official record on Congress.gov

Sponsors

Action history

DateChamberActionStatus effect
2026-05-19HouseReferred to the House Committee on Energy and Commerce.refer
2026-05-19Introduced in Houseintroduce
2026-05-19Introduced in Houseintroduce
Source: GovInfo Bill Status (Library of Congress), fetched 2026-09-20. Provisions and opinion polling arrive in a later release.